Estimating the prevalence of injection drug use among black and white adults in large U.S. metropolitan areas over time (1992-2002): Estimation methods and prevalence trends

Journal of Urban Health

Volumn 85, Issue 6, 2008, Pages 826-856

  Cooper, Hannah L F ^a   Brady, Joanne E ^b   Friedman, Samuel R ^b,c   Tempalski, Barbara ^b   Gostnell, Karla ^b   Flom, Peter L ^b,d  

^a EMORY UNIVERSITY   (United States)

^b NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d Brainscope   (United States)

Author keywords

Epidemiology; Injection drug use; Metropolitan statistical areas; Race ethnicity

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AFRICAN AMERICAN; ARTICLE; CENTRAL TENDENCY BIAS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG USE; ETHNIC GROUP; EUROPEAN AMERICAN; FEMALE; HEALTH CARE SYSTEM; HEALTH SURVEY; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INCIDENCE; INJECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RESIDENTIAL AREA; SOCIAL STATUS; STATISTICAL MODEL; UNITED STATES; VALIDATION PROCESS;

ADULT; AFRICAN AMERICANS; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; HEALTH SURVEYS; HIV INFECTIONS; HUMANS; MODELS, STATISTICAL; PREVALENCE; RISK ASSESSMENT; SMALL-AREA ANALYSIS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS; UNITED STATES; URBAN HEALTH; URBAN HEALTH SERVICES;

EID: 57049145322     PISSN: 10993460     EISSN: 14682869     Source Type: Journal    
DOI: 10.1007/s11524-008-9304-9     Document Type: Article

References (151)

1. JC Yang D Huang Y-I Hser 2006 Long-term morbidity and mortality among a sample of cocaine-dependent black and white veterans J Urban Health 83 5 926 940
2. S Galea J Ahern K Tardiff 2003 Racial/ethnic disparities in overdose mortality trends in New York City, 1990-1998 J Urban Health 80 2 201 211
3. W Fernandez H Hackman L Mckeown T Anderson B Hume 2006 Trends in opioid-related fatal overdoses in Massachusetts, 1990-2003 J Subst Abuse Treatment 31 151 156
4. Centers for Disease Control and Prevention. HIV counseling and testing at CDC-supported sites-United States, 1999-2004. Atlanta, GA: CDC; 2006.
5. Centers for Disease Control and Prevention. Cases of HIV infection and AIDS in the United States, by race/ethnicity, 2000-2004. HIV/AIDS surveillance supplemental report. Atlanta, GA: CDC; 2006.
6. J Kendall M Sherman G Bigelow 1995 Psychiatric symptoms in polysubstance abusers: relationship to race, sex, and age Addictive Behav 20 685 690
7. H Amaro MJ Larson J Gampel E Richardson A Savage D Wagler 2005 Racial/ethnic differences in social vulnerability among women with co-occurring mental heath and substance abuse disorders: implications for treatment services J Community Psychol 33 4 495 511
8. NM Petry 2003 A comparison of African American and non-Hispanic Caucasian cocaine-abusing outpatients Drug and Alcohol Dependence 69 1 43 49
9. MA Walton FC Blow BA Booth 2001 Diversity in relapse prevention needs: gender and race comparisons among substance abuse treatment patients Am J Drug Alcohol Abuse 27 2 225 240
10. A Roberts 2000 Psychiatric comorbidity in white and African-American illicit substance abusers: evidence for differential etiology Clin Psychol Rev 20 667 677
11. R Dembo L Williams J Schmeidler 1994 Psychosocial, alcohol/other drug use, and delinquency differences between urban black and white male high risk youth Int J Addict 29 461 483
12. D Ziedonis B Rayford K Bryant B Rounsaville 1994 Psychiatric comorbidity in White and African-American cocaine addicts seeking substance abuse treatment Hosp Community Psychiatry. 45 43 49
13. CM Fuller L Borrell CA Latkin 2005 Effects of race, neighborhood, and social network on age at initiation of injection drug use Am J Public Health 95 4 689 695
14. Wright D, Gfoerer J, Epstein J. The use of external data sources and ratio estimation to improve estimates of hardcore drug use from the NHSDA. NIDA Research Monograph. Vol 167. Rockville, MD: Office of Applied Studies, Substance Abuse and Mental Health Services Administration; 1997.
15. D Wright J Gfoerer 1997 Estimation of hardcore drug users J Off Statistics 13 401 416
16. CP Archibald GC Jayaraman C Major DM Patrick SM Houston D Sutherland 2001 Estimating the size of hard-to-reach populations: a novel method using HIV testing data compared to other methods AIDS 15 Suppl 3 S41 S48
17. D Korf S Reijneveld J Toet 1994 Estimating the number of heroin users: a review of methods and empirical findings from the Netherlands Int J Addict 29 1393 1417
18. Substance Abuse and Mental Health Services Administration. Results from the 2005 National survey on drug use and health: national findings. Rockville, MD: SAMHSA; 2006.
19. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. National Survey on Drug Use & Health Methodology Reports and Questionnaires; 2007.
20. US Department of Justice Office of Justice Programs Bureau of Justice Statistics. Additional Corrections Facts at a Glance: Demographic Trends in Correctionals Populations. http://www.ojp.usdoj.gov/bjs/gcorpop.htm#CorrPopRace. Accessed January 19, 2007.
21. US Department of Housing and Urban Development. Homelessness: Programs and the People They Serve. Washington, DC: Department of Housing and Urban Development; 1999.
22. M Fendrich TP Johnson 2005 Race/ethnicity differences in the validity of self-reported drug use: Results from a household survey J Urban Health 82 Suppl 3 iii67 iii81
23. T Johnson P Bowman 2003 Cross-cultural sources of measurement error in substance use surveys Subst Use Misuse. 38 1447 1490
24. S Cox M Shipley 1997 Counting the uncatchable? An epidemiological method for counting drug misusers Soc Psychiatry Psychiatr Epidemiol 32 19 23
25. M Hickman S Cox J Harvey 1999 Estimating the prevalence of problem drug use in inner London: a discussion of three capture-recapture studies Addict 94 1653 1662
26. A Larson A Stevens G Wardlaw 1994 Indirect estimates of 'hidden' populations: capture-recapture methods to estimate the numbers of heroin users in the Australian capital territory Soc Sci Med 39 6 823 831
27. Substance Abuse and Mental Health Administration. Treatment Episode Data Set (TEDS): SAMHSA; 2007.
28. US Department of Health and Human Services. AIDS Public Information Dataset (APID): US DHHS; 2007.
29. Centers for Disease Control and Prevention. HIV Counseling and Testing in Publicly Funded Sites: CDC; 2006.
30. HL Cooper SR Friedman B Tempalski R Friedman M Keem 2005 Racial/ethnic disparities in injection drug use in large US metropolitan areas Ann Epidemiol 15 5 326 334
31. S Galea A Nandi D Vlahov 2004 The social epidemiology of substance use Epidemiol Rev 26 36 52
32. A Diez-Roux 2001 Investigating neighborhood and area effects on health Am J Public Health 91 1783 1789
33. Berkman LF, Kawachi I. Social Epidemiology. New York: Oxford University Press; 2000.
34. Kawachi I, Berkman LF. Neighborhoods and Health. New York: Oxford University Press; 2003.
35. D Nurco J Shaffer I Cisin 1984 An ecological analysis of the interrelationships among drug abuse and other indices of social pathology Int J Addict 19 441 451
36. Hunt L, Chambers C. The heroin epidemics: a study of heroin use in the United States, 1965-1975. New York: Spectrum; 1976.
37. JD Boardman B Finch C Ellison DR Williams JS Jackson 2001 Neighborhood disadvantage, stress, and drug use among adults J Health Soc Behav 42 151 165
38. Friedman SR, Tempalski B, Cooper HL, Keem M, Friedman R, Flom PL. Structural factors to guide structural intervention: predictors of IDU population size, HIV Prevalence Among IDUs, and Prevention Program Coverage for IDUs. XV International AIDS Conference. Bangkok Thailand; 2004.
39. Deborah W, Wallace R. A plague on your houses. New York: Verso; 1998.
40. M Lillie-Blanton J Anthony C Schuster 1993 Probing the meaning of racial/ethnic group comparison in crack cocaine smoking JAMA 269 8 993 997
41. HL Cooper SR Friedman B Tempalski SR Friedman M Keem 2007 Residential segregation and the prevalence of injection drug use among Black adult residents of US metropolitan areas Am J Public Health 97 2 344 352
42. Office of Management and Budget 2000 Standards for defining metropolitan and micropolitan statistical areas Federal Register 65 8228 82238
43. U.S. Bureau of the Census. State and metropolitan area data book, 1997-1998. Washington, DC: US Bureau of the Census; 1998.
44. T Pierce 1999 Gen-X Junkie: Ethnographic research with young white heroin users in Washington, DC Subst Use Misuse 34 2095 2114
45. R Wallace D Wallace 1997 Socioeconomic determinants of health: community marginalisation and the diffusion of disease and disorder in the United States BMJ 314 1341 1345
46. Census USBot. Historical metropolitan area definitions. Washington, DC: US Bureau of the Census; 2005.
47. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Treatment Episode Data Set (TEDS). Highlights-2005. National admissions to substance abuse treatment services. Rockville, MD: SAMHSA; 2006.
48. Interuniversity Consortium for Political and Social Research (ICPSR). Treatment Episode Data Set (TEDS) Series: Summary. http://webapp.icpsr.umich. edu/cocoon/SAMHDA-SERIES/00056.xml. Accessed June 4, 2007.
49. Centers for Disease Control & Prevention, National Center for HIV S, and TB Prevention, Divisions of HIV/AIDS Prevention, Statistics & Data Management Branch. AIDS Public Information Data Set-Manual, Data Through December 2002. Rockville, MD: Centers for Disease Control & Prevention; 2005:51.
50. RM Klevens PL Fleming J Li 2001 The completeness, validity, and timeliness of AIDS surveillance data Ann Epidemiol 11 7 443 449
51. Centers for Disease Control and Prevention. CTS User's Guide, CTS Version 4.0. Rockville, MD: Centers for Disease Control and Prevention; 1999 March 1999.
52. US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Treatment Episode Data Set, 1992-2005 (Concatenated): Data Collection Description; 2007.
53. Cleveland W. Visualizing Data. Summitt, NJ: Hobart Press; 1993.
54. K Wells R Klap A Koike C Sherbourne 2001 Ethnic disparities in unmet need for alcoholism, drug abuse, and mental health care American Journal of Psychiatry 158 2027 2032
55. DF Johnson FJ Sorvillo AR Wohl 2003 Frequent failed early HIV detection in a high prevalence area: implications for prevention AIDS Patient Care 17 6 277 282
56. D Metzger H Navaline 2003 Human immunodeficiency virus prevention and the potential of drug abuse treatment Clin Infect Dis 37 S451 S456
57. J Hoffman H Klein D Clark F Boyd 1998 The effect of entering drug treatment on involvement in HIV-related risk behaviors Am J Drug Alcohol Abuse 24 259 284
58. D Hartel E Schoenbaum 1998 Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City Public Health Rep 113 105 115
59. R Janssen D Holtgrave R Valdisseri M Shepherd H Gayle K De Cok 2001 The serostatus approach to fighting the HIV epidemic: preventive strategies for infected individuals Am J Public Health 91 1019 1024
60. Centers for Disease Control and Prevention. Cases of HIV infection and AIDS in the United States, by Race/Ethnicity, 1998-2002. Atlanta, Georgia: Centers for disease control and prevention; 2004.
61. T Durant K McDavid X Hu P Sullivan R Janssen K Fenton 2007 Racial/ethnic disparities in diagnoses of HIV/AIDS-33 States, 2001-2005 MMWR 56 9 189 193
62. M Cohen J Cook M Young 2004 Medically eligible women who do not use HAART: the importance of abuse, drug use, and race Am J Public Health 94 7 1147 1151
63. JA Fleishman FH Hellinger 2003 Recent trends in HIV-related inpatient admissions 1996-2000: a 7-state study JAIDS 34 1 102 110
64. RN Anderson S Bozzette M Shapiro 2000 Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States HSR: Health Serv Res 35 2 389 416
65. A Ghani C Donnelly R Anderson 2003 Patterns of antiretroviral use in the United States of America: analysis of three observational databases HIV Med 4 24 32
66. M Frischer M Hickman L Kraus F Nariani L Wiessing 2001 A comparison of different methods for estimating prevalence of problematic drug misuse in Great Britain Addict 96 1465 1476
67. M Hickman V Hope L Platt 2006 Estimating the prevalence of injecting drug use: a comparison of multiplier and capture-recapture methods in cities in England and Russia Drug Alcohol Rev 25 131 140
68. JE Brady SR Friedman HLF Cooper PL Flom B Tempalski K Gostnell 2008 Estimating the prevalence of injection drug users in the U.S. and in large U.S. Metropolitan areas from 1992 to 2002 J Urban Health 8 3 323 351
69. SR Friedman B Tempalski HL Cooper 2004 Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users J Urban Health 81 3 377 400
70. S Holmberg 1996 The estimated prevalence and incidence of HIV in 96 large US metropolitan areas Am J Public Health 86 5 642 654
71. Census USBot. Population Estimates Program Dataset: U.S. Bureau of the Census; 2007.
72. U.S. Bureau of the Census, Population Division. Estimates and projections area methodology county population estimates by age, sex, race, and hispanic origin for July 1, 2005. Washington, DC: US Bureau of the Census; 2006.
73. US Bureau of the Census. Estimates And Projections Area Methodology County Population Estimates By Age, Sex, Race, And Hispanic Origin For July 1, 2005. http://www.census.gov/popest/topics/methodology/2005_co_char_meth.html. Accessed May 31, 2007.
74. National Institutes of Health, Hepatitis C Virus Concensus Development Panel. Management of Hepatitis C: 2002. Washington, DC: National Institute of Health; 2002.
75. U.S. Dept. of Health and Human Services, National Center for Health Statistics. Multiple Cause of Death File, 1992-2002 [Computer file]: U.S. Dept. of Health and Human Services, National Center for Health Statistics; 2004.
76. European Monitoring Centre for Drugs and Drug Addiction. EMCDDA Statistical Bulletin 2005. http://stats05.emcdda.europa.eu/en/home-en.html. Accessed October 18, 2006.
77. CM Chen Y-H Yoon H-Y Yi DL Lucas 2007 Alcohol and hepatitis C mortality among males and females in the United States: a life table analysis Alcoholism: Clin Exp Res. 31 2 285 292
78. M Gasiorowwicz M Hurie A Russell N Hoxie J Vergeront 2006 Epidemiologic trends in infection, mortality, and transplants related to hepatitis C in Wisconsin Wisconsin Med J 105 1 34 39
79. MJ Alter WL Kuhnert L Finelli 2003 Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus MMWR 52 RR03 1 16
80. Centers for Disease Control and Prevention. Viral Hepatitis E: Fact Sheet. Accessed May 4 2007.
81. National Center for HIV/AIDS VH, STD, and TB Prevention at the Centers for Disease Control and Prevention. Slide set: Hepatitis D. Slide Set: Viral Hepatitis; 2006.
82. Raudenbush SW, Bryk AS. Hierarchical Linear Models: Applications and Data Analysis Methods. 2nd edn. Thousand Oaks, CA: Sage Publications; 2002.
83. Singer JD, Willett JB. Applied longitudinal data analysis: modeling change and event occurrence. New York: Oxford University Press; 2003.
84. SAS/STAT® 9.1. Computer program. Version. Cary, NC: SAS Institute; 2004.
85. SR Friedman S Lieb B Tempalski 2005 HIV among injection drug users in large US metropolitan areas, 1998 J Urban Health. 82 3 434 445
86. S Holmberg 1996 The estimated prevalence and incidence of HIV in 96 large US metropolitan areas Am J Public Health. 86 642 654
87. Massey D, Denton N. American apartheid: segregation and the making of the underclass. Boston, MA: Harvard University Press; 1998.
88. Smedley B, Smith A, Nelson A. Unequal treatment: confronting racial and ethnic disparities in health care. Washington, DC: National Academies Press; 2003.
89. P Easterbrook J Keruly T Creagh-Kirk D Richman 1991 Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease JAMA 266 19 2713 2718
90. R Moore J Hidalgo B Sugland R Chaisson 1991 Zidovudine and the natural history of the Acquired Immunodeficiency Syndrome N Engl J Med 324 20 1412 1416
91. R Moore D Stanton R Gopalan R Chaisson 1994 Racial differences in the use of drug therapy for HIV disease in an urban community N Engl J Med 330 11 763 768
92. P Rosenberg M Gail L Schrager 1991 National AIDS incidence trends and the extent of Zidovudine therapy in selected demographic and transmission groups JAIDS 4 4 392 401
93. M Stein J Piette V Mor 1991 Difference in access to Zidovudine (AZT) among symptomatic HIV-infected persons J Gen Intern Med 6 35 40 January/February
94. W Woods J Guydish J Sorenson A Coutts A Bostrom A Acampora 1999 Changes in HIV-related risk behaviors following drug abuse treatment AIDS 13 2151 2155
95. H Thiede N Harris J McGough B Roberts R Khabbaz J Kaplan 1994 Prevalence of HTLV Types I and II Among Drug Users in King County, Washington West J Med 160 540 544
96. C Kwiatkowski R Booth 2001 Methadone maintenance as HIV risk reduction with street-recruited injecting drug users JAIDS 26 483 489
97. K Wells R Klap A Koike C Sherbourne 2001 Ethnic disparities in unmet need for alcoholism, drug abuse, and mental health care Am J Psychiatry 158 2027 2032
98. KT Bernstein A Bucciarelli TM Piper C Gross K Tardiff S Galea 2007 Cocaine- and opiate-related fatal overdose in New York City, 1990-2000 BMC Public Health 7 31
99. JE Kallan 1998 Drug abuse-related mortality in the United States: patterns and correlates Am J Drug Alcohol Abuse 24 1 103 117
100. Office of Applied Studies, Substance Abuse and Mental Health Services Administration. Treatment admissions in urban and rural areas involving abuse of narcotic painkillers:2002 update. Washington, DC: SAMHSA; 2004.
101. U.S. Dept. of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Treatment Episode Data Set (TEDS), 1992-2005, Concatenated data [Computer file]: Ann Arbor, MI: Inter-university Consortium for Political and Social Research [producer and distributor]; 2007.
102. Hennekens CH, Buring JF. Epidemiology in Medicine. Boston, MA: Little, Brown and Company; 1987.
103. US Department of Health and Human Services (US DHHS), Centers for Disease Control and Prevention (CDC), National Center for HIV SaTPN. AIDS Public Information Data Set (APIDS) US Surveillance Data for 1981-2002, CDC WONDER On-line Database: CDC; December 2005.
104. JK Louie LC Hsu DH Osmond MH Katz SK Schwarcz 2002 Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998 J Infect Dis 186 7 1023 1027
105. NT Harawa S Greenland TA Bingham 2004 Associations of Race/Ethnicity With HIV Prevalence and HIV-related behaviors among young men who have sex with men in 7 urban centers in the United States JAIDS 35 5 526 536
106. BJ Kottiri SR Friedman A Neaigus R Curtis DC Des Jarlais 2002 Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users JAIDS 30 1 95 104
107. DC Des Jarlais C McKnight J Milliken 2004 Public funding of US syringe exchange programs J Urban Health 81 1 118 121
108. Lurie P, Reingold A. The public-health impact of needle-exchange programs in the United States and abroad: summary, conclusions, and recommendations. San Francisco: University of California, San Francisco, Institute for Health Policy Studies; 1993.
109. Normand J, Vlahov D, Moses L. Preventing HIV transmission: the role of sterile needles and bleach. Washington, DC: National Academy Press/National Research Council/Institute of Medicine; 1995.
110. B Tempalski P Flom S Friedman 2007 Social and political factors predicting the presence of syringe exchange programs in 96 US metropolitan areas Am J Public Health. 97 3 437 447
111. S Burris J Welsh M Ng M Li A Ditzler 2002 State syringe and drug possession laws potentially influencing safe syringe disposal by injection drug users J Am Pharm Assoc. 42 6 Suppl 2 S94 S98
112. W Cunningham LE Markson RM Anderson 2000 Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the United States JAIDS. 25 115 123
113. Human Rights Watch. Targeting blacks: drug law enforcement and race in the United States. New York: Human Rights Watch; 2008.
114. KM Blankenship AB Smoyer SJ Bray K Mattocks 2005 Black-white disparities in HIV/AIDS: the role of drug policy and the corrections system J Health Care Poor Underserved. 16 4 Suppl B 140 145
115. YI Martin B James NR Rajeev F Terry 2005 How criminal system racial disparities may translate into health disparities J Health Care Poor Underserved 16 4 Supplement B 48 56
116. U.S. Department of Justice, Office of Justice Programs, Bureau of Justice Statistics. Incarcerated parents and their children. Washington, DC: US Department of Justice; 2000.
117. S-Y Kang S Deren J Andia HM Colon R Robles D Oliver-Velez 2005 HIV transmission behaviors in jail/prison among Puerto Rican drug injectors in New York and Puerto Rico AIDS Behav. 9 93 377 386
118. TM Hammett 2006 HIV/AIDS and other infectious diseases among correctional inmates: transmission, burden, and an appropriate response Am J Public Health 96 6 974 978
119. IA Binswanger MF Stern RA Deyo 2007 Release from prison-a high risk of death for former inmates N Engl J Med 356 2 157 165
120. SM Bird SJ Hutchinson 2003 Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996-99 Addict 98 2 185 190
121. T Kerr N Fairbairn M Tyndall 2007 Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users Drug Alcohol Depend 87 1 39 45
122. JC Thomas E Torrone 2006 Incarceration as forced migration: effects on selected community health outcomes Am J Public Health 96 10 1762 1765
123. A Neaigus VA Gyarmathy M Miller VM Frajzyngier SR Friedman DC Des Jarlais 2006 Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility JAIDS 41 4 493 503
124. CM Fuller D Vlahov D Ompad N Shah A Aria SA Strathdee 2002 High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study Drug Alcohol Depend 66 2 189 198
125. JE Sackoff DB Hanna MR Pfeiffer LV Torian 2006 Causes of death among persons with AIDS in the Era of highly active antiretroviral therapy: New York City Ann Intern Med 145 6 397 406
126. EJ Fordyce TP Singh D Nash B Gallagher S Forlenza 2002 Survival Rates in NYC in the Era of Combination ART JAIDS 30 1 111 118
127. FJ Hellinger JA Fleishman 2001 Location, race, and hospital care for AIDS patients: an analysis of 10 states Inquiry 38 3 319 330
128. KH Anderson JM Mitchell 2000 Differential access in the receipt of antiretroviral drugs for the treatment of AIDS and its implications for survival Arch Internal Medicine. 160 20 3114 3120
129. Johnston L, O'Malley P, Bachman J. Demographic subgroup trends for various licit and illicit drugs, 1975-2002. Ann Arbor, MI: Institute for Social Research; 2003.
130. US Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Division of Epidemiology S, and Prevention Research. Drug use among racial/ethnic minorities, revised. Bethesda, MD: NIH; 2003.
131. A Hamid R Curtis K McCoy E al 1999 The heroin epidemic in New York City: current status and prognosis J Psychoactive Drugs 41 375 391
132. Broz D, Ouellet LJ. Racial and ethnic changes in heroin injection in the United States: Implications for the HIV/AIDS epidemic. Drug and Alcohol Dependence. In press.
133. JJB Taylor 1990 Factors affecting alcohol consumption in black women, Part II Int J Addict 25 1415 1427
134. I Yen D Ragland B Greiner J Fisher 1999 Racial discrimination and alcohol-related behavior in urban transit operators: findings from the San Francisco Muni Health and Safety Study Public Health Rep 114 448 458
135. J Martin S Tuch PJ Roman SA Tuch PM Roman 2003 Problem drinking patterns among African-Americans: the Impacts of reports of discrimination, perceptions of prejudice, and "Risky" coping strategies J Health Soc Behav 44 408 425
136. G Bennet K Yaus Wolin E Robinson S Fowler C Edwards 2005 Perceived Racial/Ethnic Harassment and tobacco use among African-American young adults Am J Public Health 95 238 240
137. H Landrine E Klonoff 2000 Racial discrimination and cigarette smoking among blacks: findings from two studies Ethnicity and Disease 10 195 202
138. B Guthrie A Young D Williams C Boyd E Kinter 2002 African American girls' smoking habits and day-to-day experiences with racial discrimination Nursing Research 51 183 190
139. F Gibbons M Gerrard M Cleveland T Wills G Brody 2004 Perceived discrimination and substance use in African American parents and their children: a panel study Journal of Personality and Social Psychology 86 517 529
140. Iceland J, Weinberg DH, Steinmetz E. Racial and ethnic residential segregation in the United States: 1980-2000. Washington, DC: U.S. Census Bureau; 2002.
141. PJ Davidson RL McLean AH Kral AA Gleghorn BR Edlin AR Moss 2003 Fatal heroin-related overdose in San Francisco, 1997-2000: a case for targeted intervention J Urban Health 80 2 261 273
142. G Oxman S Kowalski L Drapela 2000 Heroin overdose deaths-Multnomah county, Oregon, 1993-1999 MMWR 49 28 633 636
143. D Solet H Hagan J Nakagawara A Plough J Ball 2000 Unintentional Opiate overdose deaths-King County, Washington, 1990-1999 MMWR 49 28 636 640
144. S Darke J Roos D Zador S Sunjic 2000 Heroin-related deaths in New South Wales, Australia, 1992-1996 Drug Alcohol Depend 60 141 150
145. S Darke K Hetherington J Ross M Lynskey M Teesson 2004 Non-injecting routes of administration among entrants to three treatment modalities for heroin dependence Drug Alcohol Rev 23 1
146. CAC Carpentrer M Stitzer 1998 Heroin snorters versus injectors: comparison on drug use and treatment outcome in age-matched samples Drug Alcohol Depend 53 11 15
147. W Swift L Maher S Sunjic 1999 Transitions between routes of heroin administration: a study of Caucasian and Indochinese heroin users in southwestern Sydney Addict 94 71 82
148. A Mocroft S Vella T Benfield 1998 Changing patterns of mortality across Europe in patients infected with HIV-1 Lancet 352 1725 1730
149. R Hogg K Heath B Yip 1998 Improved survival among HIV-infected individuals following initiation of antiretroviral therapy JAMA 279 450 454
150. FJ Palella K Delaney A Moorman 1998 Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection N Engl J Med 338 853 860
151. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for HIV S, and TB Prevention. AIDS Public Information Data Set (APIDS) US Surveillance Data for 1981-2002, CDC Wonder On-line Database: CDC; 2005.